| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |